8-K: Earth Science Tech Expands with Acquisitions and New Ventures

Earth Science Tech, Inc. completed two acquisitions, launched a new pet and wildlife brand, and relocated its principal office, all on October 1, 2024.

Summary

• Earth Science Tech, Inc. acquired Avenvi, LLC for $1,058,788.30 in cash, with an initial payment of $258,788.30 and subsequent monthly payments of $200,000 for four months.
• The Avenvi acquisition includes approximately four acres of vacant residential real estate, a commercial property with a 5,000 square foot building, and cash or cash equivalents.
• The company also acquired Mister Meds, LLC for $54,200 in cash.
• Earth Science Tech launched Zoolzy, a pet and wildlife brand under Peaks Curative, LLC, specializing in compounded medications.
• The company relocated its principal office to a new location with 1,125 square feet, bringing the total office space to 7,125 square feet.
• As of September 30, 2024, the company has repurchased 11,545,898 shares of its common stock under its $5 million repurchase program.

Sentiment

Score: 7

Explanation: The document indicates positive growth through acquisitions and new ventures, but the related party transactions and the lack of specific financial performance data temper the overall sentiment.

Positives

• The acquisitions of Avenvi and Mister Meds expand the company's asset base and potential revenue streams.
• The launch of Zoolzy diversifies the company's product offerings into the growing pet and wildlife market.
• The relocation and expansion of office space may support future growth and operations.
• The share repurchase program demonstrates management's confidence in the company's value.

Risks

• The acquisitions involved related party transactions, which could raise concerns about potential conflicts of interest.
• The company's share repurchase program may not be fully utilized, and the company is not obligated to acquire any specific amount of shares.
• The company's expansion into new markets may present operational and financial challenges.

Future Outlook

The company's future outlook is tied to the successful integration of the acquired businesses and the growth of its new pet and wildlife brand, Zoolzy. The share repurchase program may continue to impact the company's share structure.

Management Comments

• The Board of Directors reviewed and approved the related party transactions to ensure they were no less favorable to the Company than those that could be obtained from unaffiliated third parties.

Industry Context

The acquisitions and new brand launch indicate a strategic move by Earth Science Tech to diversify its operations and expand into new markets, including real estate and the pet and wildlife industry. This is in line with a trend of companies seeking growth through acquisitions and diversification.

Comparison to Industry Standards

• The acquisition of Avenvi, which includes real estate assets, is not typical for a company in the pharmaceutical or health sector, suggesting a diversification strategy.
• The launch of Zoolzy is similar to other companies that are expanding into the pet health market, which is experiencing significant growth.
• The share repurchase program is a common practice among public companies to return value to shareholders, but the amount repurchased is significant relative to the program's total value.

Related Party Transactions

• The acquisition of Avenvi, LLC involved Giorgio R. Saumat, the company's CEO and Chairman of the Board, as the seller.
• The acquisition of Mister Meds, LLC involved Mario G. Tabraue, the company's COO and a Director of the Board, as the seller.

Stakeholder Impact

• Shareholders may view the acquisitions and share repurchase program positively.
• Employees may be impacted by the office relocation and the integration of new businesses.
• Customers of the new Zoolzy brand will be impacted by the new product offerings.

Next Steps

• The company will likely focus on integrating the acquired businesses and growing the Zoolzy brand.
• The company may continue to repurchase shares under the existing program.

Key Dates

Keywords

acquisitions, real estate, pet medications, share repurchase, office relocation, related party transactions, pharmacy, compounded medications